WO1998008535A3 - Method of causing selective immunosuppression using HL-60-related lectins - Google Patents
Method of causing selective immunosuppression using HL-60-related lectins Download PDFInfo
- Publication number
- WO1998008535A3 WO1998008535A3 PCT/US1997/015016 US9715016W WO9808535A3 WO 1998008535 A3 WO1998008535 A3 WO 1998008535A3 US 9715016 W US9715016 W US 9715016W WO 9808535 A3 WO9808535 A3 WO 9808535A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lectin
- treating
- causing selective
- tumor
- administering
- Prior art date
Links
- 102000004856 Lectins Human genes 0.000 title abstract 6
- 108090001090 Lectins Proteins 0.000 title abstract 6
- 239000002523 lectin Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 206010062016 Immunosuppression Diseases 0.000 title 1
- 230000001506 immunosuppresive effect Effects 0.000 title 1
- 229940121672 Glycosylation inhibitor Drugs 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU40913/97A AU4091397A (en) | 1996-08-26 | 1997-08-26 | Method of causing selective immunosuppression using hl-60-related lectins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70480296A | 1996-08-26 | 1996-08-26 | |
US08/704,802 | 1996-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998008535A2 WO1998008535A2 (en) | 1998-03-05 |
WO1998008535A3 true WO1998008535A3 (en) | 1998-05-28 |
Family
ID=24830917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/015016 WO1998008535A2 (en) | 1996-08-26 | 1997-08-26 | Method of causing selective immunosuppression using hl-60-related lectins |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4091397A (en) |
WO (1) | WO1998008535A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1122311A4 (en) | 1998-07-31 | 2002-04-17 | Kirin Brewery | Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives |
TW200617393A (en) * | 2004-11-22 | 2006-06-01 | Univ Nat Cheng Kung | Method for testing lectin |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0337799A2 (en) * | 1988-04-14 | 1989-10-18 | Incyte Pharmaceuticals, Inc. | 14-Beta-gal mammalian lectins |
WO1992019239A1 (en) * | 1991-05-01 | 1992-11-12 | University Of New Mexico | Treatment of aberrant cellular states with biomodulators |
WO1994011497A1 (en) * | 1992-11-16 | 1994-05-26 | Incyte Pharmaceuticals, Inc. | Method of causing selective immunosuppression using hl-60-related lectins |
-
1997
- 1997-08-26 WO PCT/US1997/015016 patent/WO1998008535A2/en active Application Filing
- 1997-08-26 AU AU40913/97A patent/AU4091397A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0337799A2 (en) * | 1988-04-14 | 1989-10-18 | Incyte Pharmaceuticals, Inc. | 14-Beta-gal mammalian lectins |
WO1992019239A1 (en) * | 1991-05-01 | 1992-11-12 | University Of New Mexico | Treatment of aberrant cellular states with biomodulators |
WO1994011497A1 (en) * | 1992-11-16 | 1994-05-26 | Incyte Pharmaceuticals, Inc. | Method of causing selective immunosuppression using hl-60-related lectins |
Also Published As
Publication number | Publication date |
---|---|
WO1998008535A2 (en) | 1998-03-05 |
AU4091397A (en) | 1998-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG104245A (en) | Plasma protein-containing pharmaceutical compositions | |
CA2271857A1 (en) | Method for treating symptoms of diabetes | |
CA2162600A1 (en) | Compositions Comprising Complement Related Proteins and Carbohydrates, and Methods for Producing and Using Said Compositions | |
CA2146973A1 (en) | Uses of tgf-.beta. receptor fragment as a therapeutic agent | |
DZ2172A1 (en) | Triazole derivatives useful in therapy, process for their preparation and compositions containing them. | |
ZA962536B (en) | Pharmaceutical composition for transdermal administration. | |
IL89702A0 (en) | Water soluble ibuprofen compositions,processes for the preparation thereof and pharmaceutical compositions containing the same | |
EP1273304A3 (en) | Use of interleukin-15 | |
FR2739860B1 (en) | AMPHIPHILIC COMPLEXES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THE SAME | |
OA09374A (en) | "New 1, 2, 3, 4, 5, 6-hexahydroazepino [4,5-b] indoles and 1, 2, 3, 4-tetrahydro B carbolines, their preparation processes and pharmaceutical compositions which contain them". | |
CA2278422A1 (en) | D-methadone, a nonopioid analgesic | |
EP0999219A3 (en) | Novel heparin binding peptides | |
IT8904847A0 (en) | TRACKED VEHICLE, PARTICULARLY FOR THE PREPARATION OF SKI SLOPES. | |
ATE325803T1 (en) | GLYCOCONJUGATES, GLYCOAMINO ACIDS, THEIR INTERMEDIATE PRODUCTS, AND THEIR USE | |
WO1998008535A3 (en) | Method of causing selective immunosuppression using HL-60-related lectins | |
ITMI912745A0 (en) | 5H-BENZODIAZEPE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THEIR PREPARATION. | |
WO2001030392A3 (en) | Delivery of proteins across polar epithelial cell layers | |
CA2066031A1 (en) | Methods for reducing non-target retention of immunoconjugates and metabolites thereof | |
IT8719700A0 (en) | 2-THIOMETHYL-SUSTITUTED-PYRIDINES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
IT8125431A0 (en) | DEVICE FOR THE PREPARATION OF GRAIN MATERIAL, IN PARTICULAR FOUNDRY EARTH. | |
IT8219586A0 (en) | POLYCYCLIC COMPOUNDS CONTAINING A DOUBLE BOND IN THE D-RING, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
GB2244998B (en) | Extracellular expolymer,process for its preparation and pharmaceutical compositions containing the said exopolymer | |
FR2698799B1 (en) | Machine for flattening cereal grains, in particular. | |
IT1210859B (en) | CHEMOTHERAPY COMPOUND, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS. | |
KUROKI | Performance of Meat Oligopolistic Business Group Focused on full-cost principle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998511850 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |